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The retinoblastoma 1 (RB1) tumor suppressor is a critical regulator of cell cycle progression and develop-
ment. To investigate the role of RB1 in neural crest–derived melanocytes, we bred mice with a floxed Rb1 
allele with mice expressing Cre from the tyrosinase (Tyr) promoter. TyrCre+;Rb1fl/fl mice exhibited no mela-
nocyte defects but died unexpectedly early with intestinal obstruction, striking defects in the enteric nervous 
system (ENS), and abnormal intestinal motility. Cre-induced DNA recombination occurred in all enteric 
glia and most small bowel myenteric neurons, yet phenotypic effects of Rb1 loss were cell-type specific. 
Enteric glia were twice as abundant in mutant mice compared with those in control animals, while myen-
teric neuron number was normal. Most myenteric neurons also appeared normal in size, but NO-producing 
myenteric neurons developed very large nuclei as a result of DNA replication without cell division 
(i.e., endoreplication). Parallel studies in vitro found that exogenous NO and Rb1 shRNA increased ENS 
precursor DNA replication and nuclear size. The large, irregularly shaped nuclei in NO-producing neurons 
were remarkably similar to those in progeria, an early-onset aging disorder that has been linked to RB1 
dysfunction. These findings reveal a role for RB1 in the ENS.
Introduction
Chronic intestinal pseudo-obstruction (CIPO) is the clinical indi-
cation for 9 percent of small bowel transplants (1), yet the etiology 
for these disorders remains poorly understood. CIPO is diagnosed 
when bowel motility defects cause functional, but not mechanical, 
obstruction, leading to abdominal distension, pain, malnutrition, 
and, in severe cases, dependence on parenteral nutrition or intes-
tinal transplantation for survival. It is likely that diverse genetic, 
infectious, autoimmune, metabolic, and toxic insults all contrib-
ute to CIPO etiology.
Intestinal motility and many other aspects of bowel function are 
controlled by an interconnected intrinsic network of neurons and 
glia called the enteric nervous system (ENS) (2–4). The ENS forms 
from neural crest–derived cells that migrate through fetal bowel, 
proliferate extensively, and then exit the cell cycle and differentiate 
into many different neuronal subtypes (5–7). Defects in specific 
types of enteric neurons may cause life-threatening disease, and, 
like in the central nervous system, neurons in the ENS must be 
present in the proper ratios and with correct patterning for the 
bowel to work well. Signals that control ENS precursor prolifera-
tion and cell cycle exit are incompletely understood. Furthermore, 
the ENS can be damaged in many ways, often with preferential 
effects on NO-producing enteric neurons that inhibit bowel con-
traction (8). There are also regional differences in the susceptibility 
of enteric neurons to damage that are not well understood (9).
We initially intended to develop a model of melanoma by delet-
ing the tumor suppressor retinoblastoma 1 (Rb1) in melanocytes, 
another neural crest derivative. Rb1 is frequently inactivated in 
human cancer (10) and critically regulates cell division and devel-
opment (11–16). Cyclin-dependent kinases promote cell division 
by reversibly inactivating RB1 via a hierarchical series of phosphor-
ylation events and sequential conformational changes (12, 13). 
The best understood function of RB1 is to induce cell cycle exit 
by preventing cells from entering S phase (17), but it also partici-
pates in cell cycle checkpoints in S and G2/M phases (14). RB1 is 
important not only for tumor suppression but also for develop-
ment, terminal differentiation, and tissue homeostasis (15), with 
mutations causing tissue-specific defects (18, 19). We had previ-
ously demonstrated that RB1 couples cell cycle exit with terminal 
differentiation in melanocytes (20) and therefore crossed mice 
carrying a tyrosinase-Cre (TyrCre) transgene with mice harboring 
floxed Rb1 alleles. This TyrCre transgene is expressed not only in 
the melanocyte lineage, but also in the developing ENS. We dis-
covered that Rb1 inactivation in the ENS led to a progressive, fatal, 
and very unusual defect in a subset of myenteric neurons that pro-
duce NO. These cells undergo endoreplication and develop giant, 
irregularly shaped nuclei similar to those seen in progeria. Strik-
ingly, although Rb1 is also deleted in enteric glia and other types of 
enteric neurons, these cells do not undergo endoreplication, high-
lighting the complexity of cell cycle regulation and differences in 
Rb1 dependence of distinct cell types within the ENS lineage.
Results
Rb1 loss in the ENS causes a severe intestinal motility disorder and early 
death. Rb1fl/fl mice were bred with TyrCre mice, and at P8, the resulting 
TyrCre+;Rb1fl/fl mice (Rb1 conditional KO [cKO] mice; Figure 1A) were 
present at a normal Mendelian ratio (Rb1+/+, 19%; heterozygous Rb1 
cKO, 59%; Rb1 cKO, 22%; χ2 test P = 0.5, n = 37 Cre+ mice analyzed). 
However, the P8 Rb1 cKO mice were smaller than littermates and 
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continued to grow poorly (Figure 1, B and F). By P21, Rb1 cKO mice 
were present at a lower ratio than expected (Rb1+/+, 29%; heterozygous 
Rb1 cKO, 55%; Rb1 cKO, 16%; χ2 test P < 0.001, n = 806 Cre+ mice 
analyzed). By P30, 50% of Rb1 cKO mice had died (Figure 1C). 
To determine the cause of death, Rb1 cKO animals were subjected 
to necropsy for gross and histopathologic examination of all major 
organs. We did not observe any melanocyte defects or tumors, simi-
lar to results of Tonks et al. (21), but early death prevented the study 
of late-onset melanoma. The only abnormality detected was marked 
dilation of the distal small intestine (DSI) with intraluminal stool 
or air accumulation and contraction of the more distal bowel. This 
phenotype was evident in some Rb1 cKO mice by P8 (Figure 1D; 
n = 2 out of 4 examined) and in 70% of mice at 30 days or older 
(Figure 1E; WT, n = 14; Rb1 cKO, n = 21), indicating a progressive 
bowel motility defect that likely underlies the poor growth and 
early death in these mice. Heterozygous TyrCre+;Rb1+/fl mice were 
healthy without abnormal phenotype at all ages examined (data not 
shown). Because TyrCre mice express Cre in neural crest derivatives, 
including the ENS (22–24), we hypothesized that this Rb1 mutation 
caused ENS defects.
Rb1 cKO mouse myenteric plexus neurons undergo DNA replication with-
out mitosis. The gross intestinal phenotype in Rb1 cKO mice with 
dilated proximal and relatively narrow distal bowel was reminis-
cent of human Hirschsprung disease, in which the ENS is absent 
from the distal bowel. However, histopathologic examination 
of mice at various ages from P0 to adulthood did not reveal the 
characteristic distal bowel aganglionosis of Hirschsprung dis-
ease (n = 33 mice examined). Since the ENS was present, we next 
considered the possibility that one or more cell types within the 
ENS were abnormal in Rb1 cKO mice. To test this hypothesis, 
adult mouse whole-mount preparations of the bowel muscle lay-
ers containing the myenteric plexus were stained with antibod-
ies against HuC/D for visualizing neuronal cell bodies, TuJ1 for 
visualizing neurites, and S100 or SOX10 for visualizing enteric 
glia (Figure 2, A–H). At P30, SOX10 and S100 antibodies labeled 
exactly the same cells (100% overlap) in WT and Rb1 cKO mice 
(Supplemental Figure 1; supplemental material available online 
with this article; doi:10.1172/JCI67653DS1). Quantitative analy-
sis of Rb1 cKO mice demonstrated a normal density of myenteric 
neurons in the distal small bowels and colons but a significant 
increase in enteric glial density compared with that in WT mice 
(Figure 2, I and J). Interestingly, there were also many exceptionally 
large neurons (but not glia) in the distal small bowels of Rb1 cKO 
mice that were not observed in WT animals (Figure 2, D and H). 
Large neurons were seen, but were uncommon, in the colons of Rb1 
cKO animals. To further investigate nuclear morphology in distal 
small bowel, we used an antibody against the nuclear matrix proteins 
lamin A/C (LMNA/C) in combination with HuC/D and the DNA 
dye DRAQ5 (Figure 3, A–D). This staining demonstrated very large 
nuclei with complex internal and external LMNA/C-containing 
lamina. In some cases, LMNA/C “vesicles” are contained within a 
larger nuclear lamina, and in others, smaller LMNA/C “vesicles” 
are adjacent to or contiguous with a larger nucleus (see Supple-
mental Figure 2 and Supplemental Videos 1–6). In addition to the 
unusual nuclear lamina structures, the large nuclear size suggested 
that these neurons might be replicating DNA without cell division 
(i.e., endoreplication). Alternatively, nuclear enlargement might be 
independent of DNA replication. To distinguish between these pos-
sibilities, we first attempted fluorescence-activated cell sorting and 
fluorescence in situ hybridization to estimate DNA content, but 
these techniques were not successful on the whole-mount prepa-
rations required for these studies. Therefore, we used confocal 
microscopy and integrated DRAQ5 staining intensity to estimate 
DNA content and measure nuclear volume. For these analyses, we 
used a lamin B2 antibody that stained the nuclear lamina of myen-
teric neurons but not those of other cells in the whole-mount prep-
arations (Supplemental Figure 3). This analysis demonstrated that 
nuclear volume in Rb1 cKO mice was up to 32-fold larger than that 
in WT mice and nuclear volume was directly proportional to DNA 
content (Figure 3E), consistent with endoreplication in Rb1 mutant 
myenteric neurons. To validate the hypothesis that Rb1 mutant 
myenteric neurons continue to replicate DNA after control myen-
Figure 1
Rb1 cKO mice gain weight slowly and 
die of intestinal pseudo-obstruction.  
(A) LoxP sites surrounding Rb1 exon 19 
led to inactivation by tyrosinase 
promoter–driven Cre-recombinase. 
(B) Adult Rb1 cKO mice were smaller 
than WT littermates (ruler depicts 
centimeters). (C) Rb1 cKO mice die 
prematurely; 50% of mice were dead by 
P30. (D and E) DSIs of Rb1 cKO mice 
become dilated (red arrows) and colons 
have hard dark stool scybala at (D) P8 
and (E) P30. Ce, cecum; Co, colon; 
STM, stomach; SI, small intestine; DSI, 
distal small bowel. (F) Rb1 cKO mice 
grow slowly (control, n = 33; Rb1 cKO, 
n = 33). *P < 0.05.
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teric neurons have exited the cell cycle, we injected mice with BrdU 
daily from P9 to P16 and analyzed the enteric neurons at P20 with 
an antibody against BrdU in conjunction with PGP9.5 (neuronal) 
and SOX10 (glial) immunohistochemistry. This revealed a marked 
increase in BrdU incorporation in neurons of Rb1 cKO mice com-
pared with those in WT mice (Figure 4, A, B, and E), indicating that 
Rb1 mutant myenteric neurons continue to replicate DNA at this 
age, whereas WT myenteric neurons have ceased DNA synthesis. 
Similarly, staining with an antibody against the proliferation mark-
er Ki67 (Figure 4, C, D, and F) showed that Rb1 mutant myenteric 
neurons remained in the cell cycle, whereas WT myenteric neurons 
had exited the cell cycle at this age. Some SOX10+ enteric glial cells 
were also positive for Ki67 and BrdU staining, but the percentag-
es of positive cells did not differ between Rb1 cKO and WT mice 
(Figure 4, E and F).
Nuclear enlargement is not likely to be associated with neuronal 
cell death, since we were unable to detect TUNEL-positive cells in 
the myenteric plexuses of Rb1 cKO or control mice at P30, P50, 
or P60 (data not shown). We also did not find evidence of DNA 
damage in myenteric neurons by staining with γ-H2AX antibody 
(Supplemental Figure 4).
NO-producing distal small bowel myenteric neurons are selectively affect-
ed by RB1 loss. We observed a marked variability in the nuclear size 
of myenteric plexus neurons in the distal small bowel of Rb1 cKO 
mice and hypothesized that RB1 loss may selectively affect certain 
types of myenteric neurons. If this were the case, then the affected 
cell type would likely be an abundant one, such as NO-producing 
inhibitory motor neurons or calretinin-expressing excitatory motor 
neurons. To evaluate NO-producing cells, we used nicotinamide 
adenine dinucleotide phosphate diaphorase (NADPH-d) staining 
on whole-mount preparations of the distal small bowel myenteric 
plexus at P8 and P30 (Figure 5). At P30, many NADPH-d–expressing 
neurons exhibited giant nuclei, whereas very few giant nuclei were 
observed at P8, suggesting that postnatal DNA replication with-
out mitosis in NO-producing myenteric neurons leads to progres-
sive nuclear enlargement. This is consistent with the observation 
Figure 2
Rb1 cKO mice have disorganized myenteric ganglia with giant neurons and increased enteric glia. (A–D) Whole-mount preparations of the 
myenteric plexus stained with antibodies to HuC/D (red, neuronal marker) and Tuj1 (green, neuron-specific bIII tubulin) demonstrated some very 
large myenteric neurons in Rb1 cKO mice. (E and F) S100 (green, glia cytoplasm marker) and HuC/D (red) or (G and H) SOX10 (green, glial 
protein), DRAQ5 (blue, DNA dye), and HuC/D (red) immunohistochemistry showed an increased ratio of glia to neurons and normal glial cell 
size in ganglia with very large neurons (white arrow in H). (A and B) Ganglia also appear disorganized in Rb1 cKO mice. (I) Quantitative analysis 
demonstrated approximately twice as many enteric glia in the distal small bowels and colons of Rb1 cKO mice compared with those in controls. 
Neuron numbers were equal in Rb1 cKO and control mice. (J) We confirmed an increased glia to neuron ratio by counting cells within the same 
field of view in the distal small bowel and colon. Scale bar: 100 μm (A and B); 50 μm (C–F); 20 μm (G and H). *P < 0.05 versus control. n > 1,000 
neurons and >2,000 glia per analysis.
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that the density of NO-producing neurons in the distal small bow-
els and colons of Rb1 cKO mice was normal (WT DSI, 63 ± 7 per 
mm2; Rb1 cKO, 55 ± 8.5 per mm2, P = 0.3; WT colon, 98 ± 13 per 
mm2; Rb1 cKO colon, 109 ± 12 per mm2, P = 0.4).
Further, we performed immunohistochemical staining of the 
small bowel and colon with antibodies against neuronal NO syn-
thase (nNOS), PGP9.5 (stains all neurons), and calretinin (stains 
excitatory motor neurons), along with histochemical staining for 
NADPH-d, and performed quantitative analysis (Figure 6). The 
giant nuclei (up to 7 times larger than normal cross-sectional 
area) were limited to NO-producing neurons in the distal small 
bowels of Rb1 cKO mice, whereas calretinin-expressing neurons in 
the same region of the bowel had nuclei of normal size (Figure 6, 
A, B, E–G, and I). In contrast, there were very few PGP9.5+ neurons 
or NADPH-d–expressing neurons in the colon with nuclei that 
were larger than normal (Figure 6, C, D, and H). Enteric glia in Rb1 
cKO mice also had nuclei with normal appearance. These findings 
demonstrate differential effects on the size of neuronal nuclei in 
Rb1 cKO mice and selective vulnerability of distal small bowel NO-
producing neurons to RB1 loss.
One possible explanation for these findings is that Cre may be 
expressed selectively in NO-producing small bowel myenteric neu-
rons. To evaluate this possibility, we studied the pattern of Cre 
expression in TyrCre mice by crossing them with a Cre-dependent 
enhanced yellow fluorescent protein (EYFP) reporter mouse line. 
Quantitative analysis at P30 demonstrated Cre-dependent EYFP 
expression in 100% of SOX10+ enteric glia, 62% of distal small 
bowel myenteric neurons, 17% of colon myenteric neurons, 93% 
of distal small bowel nNOS-expressing myenteric neurons, 90% 
of distal small bowel calretinin+ myenteric neurons, 76% of colon 
nNOS+ myenteric neurons, and 80% of colon calretinin+ myenteric 
neurons (Supplemental Figure 5). We also noted that, in our mice, 
12% of colon myenteric neurons had nNOS immunoreactivity 
and 12% had calretinin immunoreactivity, lower percentages than 
previously reported in BALB/c mice (25). Finally, we performed 
immunohistochemistry for PHOX2B in these mice at E10.5 
and E11.5 (Supplemental Figure 6) and found that Cre-induced 
recombination occurred with some, but not all, ENS precursors by 
E10.5 and in almost all ENS precursors by E11.5. Thus, differential 
effects of RB1 loss on cells of the ENS cannot be explained on the 
basis of asymmetric Cre expression, suggesting that NO-producing 
neurons are selectively affected by RB1 loss. We also tested the pos-
sibility that differential expression of Rb1 family members p130 
and p107 could account for the selective effects on NO-producing 
neurons but found that p107 was expressed at low levels in WT 
and Rb1 cKO myenteric neurons (Figure 7). In contrast, p130 was 
not detected in WT myenteric neurons but was present in all Rb1 
cKO myenteric neurons, suggesting that although changes in 
p130 protein abundance occur and p107 is present in myenteric 
neurons, the expression of these proteins does not account for the 
differential effects of Rb1 mutation in myenteric neuron subpopu-
lations or substitute for RB1.
NO causes proliferation of ENS precursors in vitro. The striking effect 
of the Rb1 mutation on NO-producing neurons and the limited 
effect of this mutation on other enteric neuron types raised the 
possibility that NO itself influences DNA replication in ENS 
precursors when RB1 activity is low. To test this hypothesis, we 
generated a lentivirus that silences Rb1 and confirmed activity 
using dissociated E12.5 bowel and quantitative real-time RT-PCR 
(qRT-PCR) (Supplemental Figure 7). E12.5 mouse embryonic 
midgut slices (300- to 400-μm thick) were then cultured with 
GDNF to induce ENS precursors to migrate onto the dish and 
treated with Rb1 shRNA lentivirus or a control shRNA-expressing 
virus with or without added NO donor (DETA NONOate). Virus-
infected ENS precursors identified by GFP and RET expression 
were analyzed 48 hours later using phospho-histone 3 (PH3) 
immunohistochemistry (Figure 8). These studies demonstrated 
that silencing Rb1 and the chemical NO donor DETA NONOate 
each independently increased the percentage of RET-expressing 
cells that were PH3+ (Figure 8E, 2-way ANOVA, P < 0.001). Further-
more, the NO donor induced the generation of some RET+ cells 
with very large nuclei when Rb1 was silenced (Figure 8J), even over 
2 days in culture. These data suggest that the striking phenotype 
of NO-producing myenteric neurons in Rb1 cKO mice is induced 
by a combination of Rb1 loss and high NO levels.
Intestinal motility is abnormal in Rb1 cKO mice. The preceding analy-
sis demonstrated that Rb1 cKO mice die early, develop distal small 
bowel dilation, and have very large, unusual NO-producing neu-
Figure 3
Nuclear size correlates with DNA con-
tent in myenteric neurons of Rb1 cKO 
mice. Immunohistochemistry for LMNA/C 
(green, nuclear lamina), HuC/D (red), 
and DRAQ5 (blue) demonstrated distal 
small bowel myenteric neurons with very 
large nuclei (arrow) and irregular shapes 
(arrowhead) (C and D) in Rb1 cKO mice 
but (A and B) not in WT mice. (E) Inte-
grated DRAQ5 fluorescence intensity 
values for nuclei (log2) versus nuclear vol-
ume (log2) in distal small bowel myenteric 
neurons of P85 control (blue dots) and 
Rb1 cKO mice (red dots) demonstrated 
a linear correlation between nuclear vol-
ume and DNA content in Rb1 cKO nuclei 
and confirmed that many nuclei are much 
larger than normal in Rb1 cKO mice. 
Eight to 10 different Z-stacks per animal 
were analyzed. Scale bar: 50 μm.
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rons in the region in which the bowel is dilated. We hypothesized 
that this distal small bowel dilation occurred, at least in part, 
because these neurons produced excess NO that caused smooth 
muscle relaxation. An additional potential mechanism is that 
small bowel dilation occurred because colonic dysfunction pre-
vented luminal contents from exiting the small bowel and enter-
ing the colon. If small bowel dilation was due to intrinsic defects, 
the distal small bowels of Rb1 cKO mice should remain dilated 
and contract poorly even when separated from the colons. To test 
this hypothesis, we examined spontaneous contractions of the ilea 
from 3 WT and 3 Rb1 cKO mice using an oxygenated organ bath. 
The WT small bowel contracted vigorously (Supplemental Video 
7), but Rb1 cKO small bowel was dilated (Figure 9) and contracted 
very little (Supplemental Video 8), even when separated from 
the colon. Direct analysis of distal small bowel muscle layer NO 
synthesis, based on conversion of [3H]-arginine to citrulline (26), 
also demonstrated 2.8-fold more NO synthesis in Rb1 cKO mice 
compared with that in WT mice (WT, 0.69 ± 0.16 cpm/mg/min, 
n = 4; Rb1 cKO, 1.93 ± 0.34 cpm/mg/min, n = 3, P = 0.016). For 
Rb1 cKO animals, the ilea contracted after addition of the NO 
synthesis inhibitor, l-NAME, and motility increased (Figure 9D 
and Supplemental Video 10), consistent with the hypothesis that 
NO actively inhibited contraction in the Rb1 cKO ileum but bowel 
contraction was less obvious after L-NAME addition to WT dis-
tal small bowel (Supplemental Video 9). Collectively these data 
show that there are serious motility problems in the distal small 
Figure 4
Rb1 cKO mice have an increased 
number of BrdU+ and Ki67+ myenter-
ic neurons in the distal small bowel, 
but BrdU+ or Ki67+ myenteric neu-
rons were not detected in controls. 
Mice were injected with BrdU daily 
from P9 to P16 and then sacrificed 
at P20. (A–D) Immunohistochemistry 
for PGP9.5 (red), SOX10 (purple), 
BrdU (green), and Ki67 (green) was 
used to detect neurons, glia, DNA 
synthesis, and cycling cells, respec-
tively. BrdU+ and Ki67+ neurons and 
glia were readily detectable in Rb1 
cKO mice. (B) The arrows highlight 
a large neuron with BrdU incorpora-
tion into the nucleus. (D) The arrows 
highlight a Ki67+ neuron. Arrowheads 
highlight (B) BrdU+ and (D) Ki67+ 
glia. BrdU+ and Ki67+ neurons were 
not detected in WT mice. (E and F) 
Quantitative analysis (n = 200 cells 
per bar). Scale bar: 50 μm. *P < 0.05 
versus control.
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bowels of Rb1 cKO mice that could cause poor growth and pre-
mature death. Interestingly, colon contractility patterns were also 
abnormal in Rb1 cKO mutant mice. In contrast to the control 
animals, in which an artificial stool pellet was propelled distally 
through the colon (n = 3; Supplemental Video 11), an artificial 
stool pellet inserted into the proximal colons of Rb1 cKO mice was 
propelled proximally (n = 3; Supplemental Video 12 and Figure 10). 
Collectively, these findings demonstrate severe bowel motility 
defects and are consistent with the hypothesis that a progressive 
intestinal pseudo-obstruction phenotype caused death at between 
30 and 120 days of age in Rb1 cKO mice.
Discussion
We discovered an important and previously unsuspected role 
for RB1 in the ENS. Mice with conditional, biallelic Rb1 deletion 
in the ENS appear healthy at birth but grow slowly and die as 
young adults. This early mortality appears due to marked dis-
tal small bowel distension and relative contraction of the colon, 
consistent with partial obstruction, as a result of ENS dysfunc-
tion. When we first observed the phenotype, we considered the 
possibility that Rb1 cKO mice had distal bowel aganglionosis 
similar to that in human Hirschsprung disease, but many mice 
lived longer than would be expected if there were a region with-
out ganglion cells. Furthermore, although there are rare reports 
of children with Hirschsprung disease and retinoblastoma, this 
probably results from contiguous gene deletion that includes 
EDNRB at 13q22 and RB1 at 13q14.2 (27, 28). Instead, we dis-
covered that Rb1 cKO mice had a normal number of myenteric 
neurons in the small bowel and colon and a 2-fold increase in 
enteric glia. We also found a subset of NO-producing neurons 
with very large, irregularly shaped nuclei primarily in the distal 
small bowel. Analysis of contractility in isolated bowel segments 
demonstrated severe motility defects in both small bowels and 
colons of Rb1 cKO mice.
The etiology of intestinal motility problems in Rb1 cKO mice 
remains incompletely understood. Our data suggest that the 
enlarged nitrergic neurons in distal small bowel produced excess 
NO, a neurotransmitter that causes bowel smooth muscle relaxation. 
Although this could provide a reasonable explanation for the dilated 
distal small bowels observed in most Rb1 cKO mice, colon motility 
defects were also evident and probably contributed to poor growth 
and early death in these animals. It is possible that the increased 
number of enteric glia altered motility in small bowel or colon, since 
glia appear to affect synaptic function, but the role of glia in intes-
tinal motility is still poorly understood (29). Furthermore, there are 
approximately equal elevations in glial density in the small bowel and 
colon, implying that increased glial numbers are unlikely to account 
for both poor contractility in the dilated small bowel and for the 
abnormal motility in the contracted colon. There is undoubtedly 
more to learn about how Rb1 mutations affect ENS function and 
bowel motility, but the complexity of neural mechanisms that influ-
ence bowel function will make this work challenging.
Intestinal pseudo-obstruction and ENS defects have been 
described in previous studies mating TyrCre mice with animals 
with Ercc1 floxed alleles (23) or Pten floxed alleles (24), consistent 
with efficient recombination of floxed genes within the ENS with 
this Cre-expressing mouse line, but the expression pattern of the 
TyrCre transgene was not previously well defined. Our analysis 
shows that the TyrCre transgene induces DNA recombination in 
all enteric glia and most distal small bowel myenteric neurons as 
well as in a smaller subset of colon myenteric neurons but not in 
other cells of the bowel wall, supporting the hypothesis that the 
phenotype observed results from ENS defects.
The ENS phenotype after Rb1 deletion is complex and reflects 
the cell-type and context specific roles that RB1 plays in other tis-
sues. RB1 critically regulates the cell cycle by binding to and inhib-
iting E2F proteins that activate cyclin synthesis. RB1 inactivation 
should therefore promote cell cycle entry and, if cell division is 
complete, lead to increased cell number. Remarkably, although 
Rb1 is inactivated in Rb1 cKO mice in many myenteric neuron 
and glial progenitors, we observed 3 distinct cellular outcomes in 
many myenteric neuron and glial progenitors. Enteric glia in Rb1 
cKO mice appeared to undergo one additional round of cell divi-
sion, leading to a 2-fold increase in glia number. Many myenteric 
neurons, in contrast, did not appear to be affected by Rb1 inac-
tivation or at least did not enter the cell cycle, as demonstrated 
by Ki67 staining. However, the most remarkable change occurred 
within NO-producing myenteric neurons, in which exceptionally 
large and irregularly shaped nuclei appeared to occur as a result 
of endoreplication. Endoreplication is a process in which cells go 
through G1 and S phases and enter the G2 phase of the cell cycle 
but do not undergo mitosis or cytokinesis.
The precise mechanism that induces endoreplication selectively 
in NO-producing myenteric neurons in Rb1 cKO mice is unknown. 
A plausible hypothesis is suggested by the known biological effects 
of NO and RB1. RB1 loss enhances E2F activity, but this is not 
enough by itself to induce most postmitotic myenteric neurons to 
progress through the cell cycle and start DNA replication. How-
ever, NO has complex dose-dependent effects, including the acti-
vation of AKT and ERK at low levels. In contrast, at high levels, 
NO induces production of toxic-free radicals (e.g., peroxynitrite 
anions) that may increase susceptibility of NO neurons to many 
types of damage (8, 30–32). Interestingly, NO levels in the hip-
pocampus at baseline, (i.e., without activation of NOS) are in the 
Figure 5
NADPH-d–expressing myenteric neurons with large nuclei appeared 
as mice aged. Distal small bowel myenteric plexus neurons were visu-
alized with the NADPH-d method that stains NO-producing neurons. 
Large neurons were easy to find after P30 but not present at P8. Arrows 
highlight NADPH-d+ neurons in Rb1 cKO mice that are larger than 
normal. Scale bar: 100 μm.
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Figure 6
Most giant neurons in distal small bowel myenteric plexus express nNOS. (A–F) Whole-mount myenteric plexus stained with antibodies to nNOS 
(green, NO-producing neurons), calretinin (red, excitatory motor neurons), PGP9.5 (red, all neurons), and lamin B2 (green, nuclear lamina) or 
by NADPH-d histochemistry (NO-producing neurons). (G–I) Nuclear area for DSI and colon neurons based on lamin B2 staining. Graphs show 
cumulative frequency for nuclear area. Each point represents the percentage of neurons with nuclear area smaller than the x axis value in μm2. 
(A–D) Typical images of calretinin- and nNOS-expressing neurons in the distal small bowel (A and B) or colon (C and D) myenteric plexus of 
control (A and C) orRb1 cKO (B and D) mice. (E and F) Triple labeling for PGP9.5, lamin B2, and NADPH-d in DSIs of control and Rb1 cKO 
mice. The arrows highlight a large neuron. (G) Quantitative analysis shows that many NADPH-d–expressing neurons have very large nuclei in 
Rb1 cKO mice. Since NADPH-d–expressing neurons are common, it is not surprising that enough PGP9.5+ neurons have large nuclei to shift the 
curve. (H) Colon myenteric plexus neurons are very close to normal size in Rb1 cKO mice. (I) In contrast to NO-producing neurons, calretinin-
expressing myenteric neurons are near normal size in the small intestines of Rb1 cKO mice. Scale bar: 50 μm. (G–I) WT, n = 200 cells; Rb1 cKO, 
n = 300 cells per line.
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range that activates ERK and AKT (30). This may be enough to 
enhance cell cycle entry in NO-producing neurons but not in adja-
cent cells that do not produce NO. Consistent with this hypoth-
esis, we demonstrated in vitro that a chemical NO donor increased 
levels of histone 3 (H3) phosphorylation in ENS precursors. H3 
phosphorylation starts in late G2 phase, increases through late 
prophase, and continues through metaphase (33). Dephosphory-
lation of H3 begins in anaphase and ends in telophase. Thus, our 
results are consistent with the hypothesis that Rb1-deficient NO-
producing myenteric neurons enter the cell cycle in response to 
NO and progress to G2/M but do not complete mitosis, leading to 
endoreplication and neurons with very large nuclei.
The reason that NO-producing myenteric neurons do not com-
plete mitosis, while enteric glia and many other cell types prolifer-
ate in response to Rb1 loss, is uncertain. However, modeling of the 
cell cycle using 45 simultaneous differential equations suggests 
that endoreplication occurs when cells have high levels of the 
CDH1 (FZR1), an activator of the E3-ubiquitin ligase anaphase-
promoting complex (APC) (34). Postmitotic neurons in the cen-
tral nervous system are known to have high levels of CDH1/APC 
activity that regulate axon growth and patterning, and prevent 
cell death (35), but we were unable to obtain good antibodies 
for immunohistochemistry that would permit colocalization of 
CDH1 and nNOS within the myenteric plexus. NO-producing 
neurons may therefore selectively enter the cell cycle because of 
trophic effects of NO but fail to undergo mitosis, leading to cycles 
of endoreplication in the setting of high CDH1 levels common in 
postmitotic neurons.
Our observations fit well with recent studies suggesting that 
defective RB1 signaling underlies the severe defects in nuclear mor-
phology and aneuploidy seen in several serious human diseases. 
For example, Hutchinson-Gilford progeria syndrome is caused by 
mutations in the nuclear intermediate filament protein lamin A 
(LMNA) gene. The most common disease causing mutation (LMNA 
G608G) creates an abnormal splice site, resulting in a 50–amino acid 
deletion that eliminates a cleavage site for the protease ZMPSTE24 
that normally removes the farnesylated and carboxymethylated 
C terminus of LMNA. LMNA binds directly to hypophosphory-
lated RB1 during the G1 phase of the cell cycle and protects RB1 
from proteasomal degradation (36). Gene expression profiling of 
HGPS fibroblasts also demonstrated that Rb1 mRNA levels are low 
in HGPS cells and that RB1 is the only known LMNA-interacting 
protein whose expression is abnormal compared with that of con-
trol cells (37). Results of additional studies using a farnesyltransfer-
ase inhibitor are consistent with the hypothesis that loss of RB1 is 
the primary direct effect of the LMNA mutation studied. A major 
Figure 7
RB1 family members p107 and 
p130 in the DSI of P30 WT and 
Rb1 cKO mice were evaluated by 
immunohistochemistry. (A) p107 
immunoreactivity was detected in 
neurites at a low level but not in 
neuron cell bodies. (B) p130 immu-
noreactivity was easily detected in 
all myenteric neurons of the Rb1 
cKO mouse but was difficult to 
detect in the WT mouse. The white 
arrows show a myenteric neuron 
(HuC/D+) that expresses p130 but 
is not stained with NADPH-d his-
tochemistry. Arrowheads show an 
NADPH-d histochemistry positive 
NO-producing neuron that also 
expresses p130. Scale bar: 50 μm 
(A and B, lower right), 20 μm.
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role for reduced RB1 activity in lamin-related diseases is also sug-
gested by the similar appearance of cells from LmnaDhe mice to that 
of the nNOS-expressing myenteric neurons in our Rb1 cKO ani-
mals (38). The LmnaDhe mutation is a spontaneous semidominant 
point mutation (L52R) that causes skin and hair changes that are 
similar to those in human progeria. The mutation is in the coiled-
coil domain of lamin proteins and is predicted to disrupt structures 
needed for self association (39). Defects in nuclear morphology 
and misregulation of the cell cycle are also reported in association 
with increased RB1 phosphorylation (i.e., inactivation) in TDP-43 
mutant mice (40). TDP-43 mutations occur in people with amyo-
trophic lateral sclerosis, and TDP-43 aggregates are found in many 
neurodegenerative diseases. Finally, acute Cre-mediated Rb1 recom-
bination to delete exon 19 using the same conditional mice that we 
studied caused increased DNA synthesis, but a block in mitosis in 
hepatocytes led to cells with 16N ploidy (19), similar to the effect 
in “postmitotic” NO-producing myenteric neurons. In contrast, 
acute Rb1 inactivation in the proliferative cells of the gastrointes-
tinal tract of the same mice led to increased DNA synthesis and 
increased mitoses without mitotic uncoupling, similar to what 
we saw in enteric glia. Progression to mitosis depends on cyclin 
B1 accumulation, and differences in cyclin B1 levels may under-
lie the differences in cellular response after Rb1 inactivation. Our 
studies lend strong support for the hypothesis that many of the 
LMNA-associated changes in cell cycle control and nuclear mor-
phology are due to reduced RB1 activity.
Summary. Rb1 cKO mice die prematurely with symptoms of intes-
tinal pseudo-obstruction. These mice have serious defects in ENS 
structure and intestinal contractility but also have a normal com-
plement of myenteric neurons. The most striking finding is that, 
while most myenteric neurons have a normal morphologic appear-
ance, many small bowel NO-producing myenteric neurons undergo 
endoreplication as a result of RB1 loss. We hypothesize that the 
selective effect of RB1 loss in these cells is a reflection of the unique 
biochemistry of NO, which promotes cell proliferation and sur-
vival at low levels and damages DNA and proteins at high levels. 
Why the NO-producing neurons with giant nuclei are confined to 
the small intestine is not known but may reflect differences in NO 
production or in Cre expression in colon and small bowel myen-
teric neurons. The remarkable similarity in nuclear morphology in 
small bowel NO-producing myenteric neurons in Rb1 cKO mice to 
the enlarged nuclei found in cells with LMNA mutations that cause 
progeria is consistent with a critical role for reduced RB1 activity 
hypothesized to be important in the pathophysiology of progeria.
Methods
Mice. Characterization of the floxed Rb1, TyrCre, and R26REYFP reporter 
mice has been reported previously (22, 41, 42). Floxed Rb1 (Rb1fl/fl) mice 
Figure 8
NO donor and Rb1 silencing 
increased cell cycle entry in ENS 
precursors. (A–H) E12.5 midgut 
slices were cultured (B, D, F, and H) 
with or (A, C, E, and G) without 
the NO donor DETA NONOate and 
(C, D, G, and H) with lentivirus 
expressing shRNA against Rb1 or 
(A, B, E, and F) a control lentivi-
rus for 48 hours. (D and H) Arrow-
heads indicate Rb1 shRNA lentivi-
rus–infected ENS precursors with 
enlarged nuclei in the presence of 
NO donor. Antibodies to RET (blue) 
and PH3 (red) were used to iden-
tify neural crest–derived cells and 
cells in the cell cycle, respectively. 
(I) Quantitative analysis of neural 
crest–derived (RET+), virus-infected 
(GFP+) cells in the cell cycle (PH3+). 
(J) Quantitative analysis of nuclear 
area for RET+GFP+ cells after virus 
infection and NO donor or control 
culture. In box-and-whisker plot, 
horizontal bars indicate the medi-
ans, boxes indicate 25th to 75th 
percentiles, and whiskers indicate 
10th and 90th percentiles. Scale 
bar: 20 μm. *P < 0.001 for Rb1 
shRNA and for DETA NONOate 
versus controls, 2-way ANOVA.
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mucosa using fine-pointed forceps under a dissecting microscope. Sam-
ples from DSI and colon were cut into 1-cm segments and stored in 50% 
glycerol/PBS at –20°C until staining and analysis.
Whole-mount immunohistochemistry. Myenteric whole-mount preparations 
were permeabilized and blocked with 10% donkey serum/TBST (100 mM 
Tris, 150 mM NaCl, 1% Triton X-100) for 1 hour and then incubated for 
18 hours at 4°C (or 2 hours at 37°C for lamin antibodies) with the follow-
ing primary antibodies: mouse biotinylated-HuC/D (1:250; Invitrogen), rab-
bit TuJ1 (1:10,000; Covance), goat SOX10 (1:250; Santa Cruz Biotechnology 
Inc.), goat LMNA/C (1:250; Santa Cruz Biotechnology Inc.), mouse lamin B2 
(1:250; Invitrogen), rabbit PGP9.5 (1:500; AbD Serotec), rabbit S100 (1:1,000; 
DAKO), rabbit Ki67 (1:250; Abcam), Alexa Fluor 488 conjugated to anti-
BrdU mouse monoclonal antibody (1:100; Invitrogen), goat calretinin (1:250; 
Chemicon), rabbit nNOS (1:250; Chemicon), rabbit γH2AX (1:400; Bethyl 
Laboratories), PHOX2B (1:10,000, a gift from J.F. Brunet, Institut de Biologie 
de I’École Normale Supérieure, Paris, France), rabbit p107 (C-18) (1:50; Santa 
Cruz Biotechnology Inc.), rabbit p130 (C-20) (1:50; Santa Cruz Biotechnology 
Inc.), goat RET (1:100; Neuromics), and rabbit PH3 (S10) (1:100; Cell Signal-
ing). Donkey secondary antibodies used were Alexa Fluor 488, 594, or 647 
(1:500; Invitrogen). Nuclei were counterstained with DRAQ5 (1:2,000; Cell 
Signaling) or DAPI. TUNEL assay was performed with the In Situ Cell Death 
Detection TMR Red Kit (Roche Applied Science; positive control: DNase I 
treatment). Specimens were mounted on slides in 50% glycerol in PBS and 
were obtained from the National Cancer Institute Mouse Repository (strain 
01XC1; Frederick, Maryland, USA). This strain carries a conditional mutation 
in the endogenous Rb1 gene, with LoxP sites inserted into introns surround-
ing exon 19 (41). Mice with a tyrosinase promoter driving Cre expression 
(TyrCre mice) were provided by Graham F. Kay (Queensland Institute of Med-
ical Research, Herston, Queensland, Australia) (22). R26REYFP reporter mice 
(B6.129X1-Gt[ROSA]26Sortm1[EYFP]Cos/J) were used to monitor expression of the 
Cre transgene (The Jackson Laboratory; C57BL/6J background) (42). TyrCre+ 
mice (C57BL/6J background) were crossed with floxed Rb1 mice (FVB/129 
background), which were subsequently interbred for 5 to 7 generations to 
generate Rb1 cKO mice, TyrCre+;Rb1fl/+ (conditional heterozygous Rb1 cKO) 
mice, and control mice that either lack Cre or lack floxed Rb1 alleles. Mice 
were genotyped for Cre, Rb1, or GFP by PCR analyses, as previously described, 
using DNA extracted from tail or ear biopsies (22, 41). For timed pregnancies, 
the day on which the vaginal plug was detected was considered E0.5. Sur-
vival curves were determined by Kaplan-Meier analysis for Rb1+/+ and Rb1fl/fl 
animals carrying the TyrCre transgene (i.e., control and Rb1 cKO animals).
Myenteric whole-mount preparations. Mice were euthanized by carbon diox-
ide asphyxiation (adult) or cervical dislocation (<P14). The gastrointestinal 
tract was removed, flushed with ice-cold PBS, opened by cutting along the 
mesenteric border, flattened, and pinned mucosal side down on Sylgard 
dishes. After fixation with 4% paraformaldehyde (30 minutes), muscle 
layers containing myenteric plexus were separated from mucosa and sub-
Figure 9
Rb1 cKO distal small bowel contractil-
ity is abnormal. (A and B) Kymographs 
were generated from video images 
of (A) a WT and (B) a mildly affected 
Rb1 cKO mouse distal small bowel 
maintained in an oxygenated organ 
bath. Bowel lumen was not perfused or 
stimulated during video imaging. Mutant 
bowel was dilated compared with WT 
bowel. (C and D) The same segments 
of bowel as in A and B are shown but 
with NOS inhibitor l-NAME added within 
15 seconds of recording (arrows). Kymo-
graphs show the width of the bowel (via 
color coding) at a particular position 
(x axis) and a particular time (y axis). 
Proximal bowel is on the left.
Figure 10
Rb1 cKO mouse colon contracts abnormally. 
Colon was maintained in an oxygenated organ 
bath. An artificial stool pellet was inserted into 
proximal colon (left). Kymographs show colon 
width (by a color code) at specific positions 
(x axis) and times (y axis). (A) WT colon propelled 
the pellet distally, (B) but Rb1 cKO colon expelled 
the pellet from the proximal end.
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4°C at 500 × g, filtered with a 0.22-μm syringe top filter, and stored in 
aliquots at –80°C until use.
qRT-PCR. Bowel from E12.5 CF-1 mouse was dissociated with dispase and 
collagenase and cultured as described previously (45). Lentivirus was added 
after 16 hours of culture. Medium was replaced after 24 hours, and cells 
were collected for RNA purification 48 hours after virus addition. Reverse 
transcription was carried out using 10 ng total RNA and SuperScript III 
(Invitrogen) following the manufacturer’s protocol. Fast SYBR Green Mas-
ter Mix (Applied Biosystems) was used to quantify relative Rb1 mRNA levels 
by qRT-PCR with a Mx3005P (Agilent Technologies) instrument and Rb1 
primers (forward 5′CCTTGAACCTGCTTGTCCTC3′, reverse 5′TGAGGCT-
GCTTGTGTCTCTG3′) as well as GAPDH primers (forward 5′AACTTTG-
GCATTGTGGAAGG3′, reverse 5′ GGATGCAGGGATGATGTTCT3′).
ENS precursor culture for Rb1 shRNA and DETA NONOate studies. E12.5 
mouse midgut slices (300- to 400-μm thick) were cultured on fibronectin-
coated (250 μg/ml; GIBCO) 8-well glass chamber slides (NUNC, catalog 
no. 177402) in DMEM with chicken embryo extract (10% chicken embryo 
extract; Seralab); N2 (1%; Invitrogen); B27 (2%; Invitrogen); bFGF (20 ng/ml; 
R&D Systems); EGF (20 ng/ml; Calbiochem); retinoic acid (35 ng/ml; 
Sigma-Aldrich); and β-mercaptoethanol (50 μM; Sigma-Aldrich). Four 
hours after plating, GDNF was added (50 ng/ml) to induce enteric neural 
crest–derived cell migration from the slice. Sixteen hours later, cultures 
were treated with control virus (5 × 106 CFU/ml) or Rb1 shRNA virus 
(2 × 106 CFU/ml) containing medium and DETA NONOate (Cayman). 
Medium was replaced with fresh DMEM, chicken embryo extract, and DETA 
NONOate after 24 hours, and cultures were fixed (30 minutes at 25°C) in 
4% paraformaldehyde 48 hours after virus and DETA NONOate addition.
Functional motility analysis. DSIs and colons from Rb1 cKO and WT litter-
mates were pinned to Sylgard and maintained in a 37°C water bath with 
20 ml oxygenated (95% O2 and 5% CO2) physiological saline solution of the 
following composition: 1x Krebs buffer (Sigma-Aldrich, product no. K4002) 
with additional d-glucose 2 g/l, NaHCO3 2.1 g/l, and CaCl2 0.28 g/l. The 
saline was continuously superfused through the organ bath at a flow rate of 
15 ml/min. After 30 minutes equilibration, an artificial pellet was placed at 
the proximal end of the colon. Video images were recorded for 25 minutes 
before adding a NOS blocker (100 μM l-NAME) (Cayman) to the water bath.
Video imaging. Video images were captured at ×0.67 optical magnification 
with an E-PM1 Olympus digital video camera mounted on a dissecting 
microscope (15 frames per second, 1,920 × 1,080 pixels resolution). AVIDE-
MUX version 2.6.1 software was used to convert MTS to Avi format. Then, 
files were converted from Avi to SU2 format using software (Scribble v.2) 
provided by Joel C. Bornstein (Department of Physiology, University of 
Melbourne, Parkville, Victoria, Australia). Finally, spatiotemporal maps 
were generated and analyzed with custom software (Analyze) also devel-
oped by Joel C. Bornstein’s group using MATLAB 7.0.4. (46).
Measurement of NO synthesis in bowel muscle layers. The small intestine from 
10 cm distal to the stomach to 10 cm proximal to the cecum was dissected 
in oxygenated 1× Krebs buffer (Sigma-Aldrich, product no. K4002) with 
additional 2 g/l d-glucose, 2.1 g/l NaHCO3, and 0.28 g/l CaCl2 to separate 
smooth muscle layers, including the myenteric plexus from submucosa and 
mucosa. These muscle layers were incubated in l-[3H] arginine (3 μCi/ml; 
PerkinElmer) at 37°C for 15 minutes to permit conversion of arginine to 
citrulline and NO. Tissue was flash frozen in liquid nitrogen and stored 
at –80°C until analysis. l-[3H] citrulline was extracted by homogenizing 
weighed muscle preparations (Dounce homogenizer) and precipitating pro-
tein with 1 M trichloroacetic acid (Sigma-Aldrich), water/ether extraction 
(×3), and column chromatography (Dowex AG50WX-8 [Sigma-Aldrich] 
Na+form) as described previously (26) before scintillation counting.
Statistics. Student’s t test was used when comparing WT mice to Rb1 cKO 
mice. For studies in which enteric neural crest–derived cells were treated 
observed using upright laser scanning confocal microscopes (Zeiss LSM 510 
and Olympus FV1000). Tissue specimens were excited using argon (488 nm), 
HeNe1 (543 nm), and HeNe2 (633 nm) lasers, with excitation and barrier fil-
ters set for individual fluorophores according to their specific excitation/
emission spectra (λ = 488 nm, 594 nm, 647 nm). The detection pinhole was 
set for use with different objectives accordingly. Offset and gain settings were 
determined at the start of each experiment and kept constant throughout, 
with laser power recorded each time.
Reduced NADPH-d staining. NO-producing inhibitory neurons were visual-
ized in myenteric whole-mount preparations using NADPH-d staining (43). 
Stained samples were examined under a bright-field microscope, and neurons 
were counted using a 1.0 × 1.0 mm2 grid counting eyepiece (×10 objective). 
Twenty randomly selected fields were counted for each region, and data are 
presented as neurons per mm2. Contrast and brightness of digital images 
were uniformly adjusted with Photoshop.
Nuclear size analysis. Nuclear size of total myenteric, calretinin-expressing, 
and NO-producing neurons was determined by triple labeling with 
NADPH-d, lamin B2, and PGP9.5 or with calretinin, lamin B2, and PGP9.5 
antibodies. A plug-in from ImageJ was used for nuclear area measurements 
(μm2), and distribution was plotted as cumulative frequency (%).
BrdU incorporation. Mice were injected with BrdU (100 μg; Invitrogen) 
intraperitoneally once daily from P9 to P16 and then analyzed at P20. 
Myenteric whole-mount preparations were permeabilized in 0.5% Triton-
X100 in PBS for 1 hour. DSI and colon were then stained for BrdU using an 
Alexa Fluor 488 anti-BrdU mouse monoclonal antibody (1:100; Invitrogen) 
for 1 hour at 37°C according to the manufacturer’s instructions. Stained 
samples were washed before blocking with 10% donkey serum/TBST for 
1 hour and then incubated for triple labeling with PGP9.5 antibody (fol-
lowed by donkey anti-rabbit Alexa Fluor 594) and SOX10 antibody (followed 
by donkey anti-goat Alexa Fluor 647). Specimens were mounted in 50% 
glycerol in PBS. PGP9.5+/BrdU+ and SOX10+/BrdU+ (WT mice, n = 4; Rb1 
cKO mice, n = 5) cells were counted in 10 fields for each region per mouse 
(DSI and colon). Fields were randomly selected using PGP9.5 staining.
DNA content analysis. DSI tissue specimens were stained with lamin B2 
antibody to delineate the nuclear lamina of the myenteric neurons. Nuclei 
were then counterstained with DRAQ5 to determine their DNA content 
(stoichiometric DNA binding; 1:2,000; 12 hours at 4°C). Z-stacks of 
myenteric plexuses were recorded using an upright laser scanning con-
focal microscope (Zeiss LSM 510) with a water immersion ×40 objective 
(0.5-μm-thick slices; 8–10 Z-stacks; 30–67 cells per animal). Measure Stack.
java software (OptiNav Inc.) downloaded to the ImageJ plug-ins folder was 
used for measurements on a series of slices from Z-stacks. The results were 
summed to determine the nuclear volume (log2) and DRAQ5 intensity 
(log2; mean gray value of pixels within the nucleus)
Rb1 shRNA. The shRNA plasmid DNA used to generate Rb1 and control 
vectors was created by the RNAi core of Washington University in St. Louis 
using the vector pLKO.1-puro that also encodes a puromycin resistance 
gene (44). The Rb1 target sequence is GCAGTGCGTTATCTACTGAAA. 
The control target sequence is CGTCGTATTACAACGTCGTGA. The 
puromycin resistance gene was replaced with EGFP from pBK-CMV using 
Bamh1 and KpnI to digest both vectors.
Lentivirus production. To produce Rb1 and control shRNA-expressing len-
tivirus, the plasmids pLKO.1 Rb1 EGFP or pLKO.1 control EGFP (1 μg) 
plus Δ8.9 (0.89 μg; BD Biosciences) and VSV-G (0.11 μg; BD Biosciences) 
were mixed in 50 μl DMEM plus FuGENE 6 (6 μl per well) for 30 minutes 
at room temperature. The plasmid mixture was added to HEK293T cells 
in 30-mm dishes (6-well dishes). Medium was replaced with 2 ml fresh 
DMEM plus chicken embryo extract (10%) 16 hours after transfection. The 
culture supernatants with virus particles were collected after 48 hours. To 
eliminate the cell debris, supernatant was centrifuged for 10 minutes at 
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